MedTrace Logo

MgSO4 Combined With Rocuronium Priming

NCT01389791 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-01-10

No results posted yet for this study

Summary

Priming with either rocuronium or MgSO4 is known to accelerate the effect of rocuronium on muscle relaxation. The purpose of this study is to define the effect of MgSO4 on the rocuronium-priming.

Conditions

  • Muscle Relaxation

Interventions

DRUG

magnesium sulfate

Patients in this group receive intravenous MgSO4 50mg/kg before administration of rocuronium (induction dose).

DRUG

priming

Patients in this group receive 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium.

DRUG

magnesium sulfate and priming

Patients in this group receive MgSO4 50mg/kg and 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium.

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Sanghwan Do, M.D., PH.D. · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01389791 on ClinicalTrials.gov